Rigel Pharmaceuticals Inc. (RIGL) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO, CA 94080 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 56,933 | 62,351 | 64,357 | 58,662 | 58,206 | 81,642 | |||
| Cash and cash equivalents | 32,786 | 45,414 | 48,812 | 40,285 | 24,459 | 29,866 | |||
| Short-term investments | 24,147 | 16,937 | 15,545 | 18,377 | 33,747 | 51,776 | |||
| Receivables | 30,550 | 23,546 | 20,819 | 29,366 | 40,320 | 15,525 | |||
| Inventory, net of allowances, customer advances and progress billings | 5,522 | 6,112 | 10,782 | 11,077 | 9,118 | 7,116 | |||
| Inventory | 5,522 | 6,112 | 10,782 | 11,077 | 9,118 | 7,116 | |||
| Advances on inventory purchases | 700 | 700 | 800 | 700 | |||||
| Other undisclosed current assets | 6,261 | 3,015 | 4,267 | 7,167 | 7,459 | 5,457 | |||
| Total current assets: | 99,266 | 95,024 | 100,925 | 106,972 | 115,903 | 110,440 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 861 | 1,008 | 997 | 1,123 | 1,930 | 2,991 | |||
| Property, plant and equipment | 165 | 190 | 215 | 294 | 857 | 1,694 | |||
| Intangible assets, net (including goodwill), including: | 13,878 | 14,146 | 14,413 | 14,681 | 14,949 | ||||
| Intangible assets, net (excluding goodwill) | 13,878 | 14,949 | |||||||
| Other undisclosed intangible assets, net (including goodwill) | 14,146 | 14,413 | 14,681 | ||||||
| Other noncurrent assets | 3,055 | 4,956 | 541 | 542 | 640 | 484 | |||
| Total noncurrent assets: | 17,959 | 20,300 | 16,166 | 16,640 | 18,376 | 5,169 | |||
| TOTAL ASSETS: | 117,225 | 115,324 | 117,091 | 123,612 | 134,279 | 115,609 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 21,152 | 21,122 | 16,992 | 17,052 | 37,859 | 29,096 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 5,661 | 8,866 | 8,773 | ||
| Accounts payable | 7,142 | 7,999 | 5,240 | 6,295 | 22,508 | 2,721 | |||
| Accrued liabilities | 14,010 | 13,123 | 11,752 | 5,096 | 6,485 | 17,602 | |||
| Deferred revenue | 1,355 | 1,355 | 1,355 | 1,369 | 1,369 | 1,369 | |||
| Debt | 7,229 | ||||||||
| Other liabilities | 3,642 | 4,826 | 5,700 | 5,620 | 4,997 | 5,912 | |||
| Other undisclosed current liabilities | 19,889 | 20,970 | 19,976 | 21,477 | 20,986 | 10,888 | |||
| Total current liabilities: | 53,267 | 48,273 | 44,023 | 45,518 | 65,211 | 47,265 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 52,373 | 59,659 | 59,574 | 59,484 | 39,448 | 39,468 | |||
| Long-term debt, excluding current maturities | 52,373 | 59,659 | 59,574 | 59,484 | 39,448 | 39,468 | |||
| Liabilities, other than long-term debt | 40,229 | 39,226 | 41,609 | 42,867 | 43,236 | 48,710 | |||
| Other liabilities | 39,944 | 38,760 | 40,981 | 42,065 | 42,264 | 48,710 | |||
| Operating lease, liability | 285 | 466 | 628 | 802 | 972 | ||||
| Total noncurrent liabilities: | 92,602 | 98,885 | 101,183 | 102,351 | 82,684 | 88,178 | |||
| Total liabilities: | 145,869 | 147,158 | 145,206 | 147,869 | 147,895 | 135,443 | |||
| Equity | |||||||||
| Equity, attributable to parent | (28,644) | (31,834) | (28,115) | (24,257) | (13,616) | (19,834) | |||
| Common stock | 175 | 175 | 175 | 174 | 174 | 173 | |||
| Additional paid in capital | 1,378,723 | 1,376,293 | 1,374,330 | 1,371,591 | 1,368,822 | 1,364,139 | |||
| Accumulated other comprehensive income (loss) | 8 | (15) | (25) | (27) | (153) | (286) | |||
| Accumulated deficit | (1,407,550) | (1,408,287) | (1,402,595) | (1,395,995) | (1,382,459) | (1,383,860) | |||
| Total equity: | (28,644) | (31,834) | (28,115) | (24,257) | (13,616) | (19,834) | |||
| TOTAL LIABILITIES AND EQUITY: | 117,225 | 115,324 | 117,091 | 123,612 | 134,279 | 115,609 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 35,792 | 28,134 | 26,886 | 26,070 | 51,278 | 22,410 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (3,790) | (1,268) | (1,075) | (977) | (342) | (250) | ||
| Gross profit: | 32,002 | 26,866 | 25,811 | 25,093 | 50,936 | 22,160 | ||
| Operating expenses | (30,036) | (31,331) | (31,078) | (37,818) | (48,857) | (40,563) | ||
| Operating income (loss): | 1,966 | (4,465) | (5,267) | (12,725) | 2,079 | (18,403) | ||
| Nonoperating income (Investment Income, Nonoperating) | 459 | 672 | 529 | 461 | 429 | 192 | ||
| Interest and debt expense | (1,907) | (1,899) | (1,862) | (1,204) | (1,107) | (826) | ||
| Income (loss) from continuing operations: | 518 | (5,692) | (6,600) | (13,468) | 1,401 | (19,037) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | (19,037) | |
| Other undisclosed net income (loss) | 219 | (68) | ||||||
| Net income (loss) available to common stockholders, diluted: | 737 | (5,692) | (6,600) | (13,536) | 1,401 | (19,037) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 3/31/2024 Q1 | 12/31/2023 Q4 | 9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 737 | (5,692) | (6,600) | (13,536) | 1,401 | (19,037) | ||
| Comprehensive income (loss): | 737 | (5,692) | (6,600) | (13,536) | 1,401 | (19,037) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 23 | 10 | 2 | 126 | 133 | 152 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 760 | (5,682) | (6,598) | (13,410) | 1,534 | (18,885) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.